Business · 12/09/2011Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting to Discuss Reauthorization of Prescription Drug User Fee Act
Summary
The FDA is holding a public meeting to gather public input on proposed recommendations for reauthorizing the Prescription Drug User Fee Act, which authorizes the agency to collect user fees for reviewing human drug applications from FY 2013 to 2017.
Original source language: Federal Register — Health and Human ServicesOpen original release →